Xconomy | Seattle - Business + Technology in the Exponential Economy

Related Posts

Biotech, Life Sciences, cancer

OncoGenex Cuts Half of Workforce, Leaving 27 Employees

Luke Timmerman 8/21/08

OncoGenex Pharmaceuticals, (NASDAQ: OGXI) the developer of cancer drugs, said today it has cut half of its workforce as part of the merger between its predecessor company and Bothell, WA-based Sonus Pharmaceuticals. After the job cuts, the company will have 27 full and part-time employees. OncoGenex stock fell 3.6 percent to $4.82 in its first day of trading.

Comments | Permalink | Share this post Share | E-mail E-mail

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map
Visit a city in our network or go to
Xconomy National
for network hightlights
Seattle Boston San Diego

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.